Initial analysis of 3227 EOC cases and 3444 matched-controls suggested that larger numbers of samples were required to determine if PALB2 was an ovarian cancer susceptibility gene (p 0.08) [11]. This evidence concerns the gene PALB2 and ovarian cancer.